Combined Inhibition of ACK1 and AKT Shows Potential Toward Targeted Therapy Against KRAS-Mutant Non-Small-Cell Lung Cancer. Biomol Biomed 2021, 21 (2), 198-207. https://doi.org/10.17305/bjbms.2020.4746.